Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 7 PT2, 2008, Pages

  Hokari, Ryota ^a   Kitagawa, Noritake ^a   Watanabe, Chikako ^a   Komoto, Shunsuke ^a   Kurihara, Chie ^a   Okada, Yoshikiyo ^a   Kawaguchi, Atsushi ^a   Nagao, Shigeaki ^a   Hibi, Toshifumi ^b   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Lymphangiectasia; VEGF C; VEGFR3

Indexed keywords

HOMEODOMAIN PROTEIN; LYVE 1 PROTEIN; MESSENGER RNA; PROTEIN; PROX 1 PROTEIN; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SOX18; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; DUODENUM MUCOSA; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHANGIECTASIA; LAMINA PROPRIA; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 47649103412     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05225.x     Document Type: Article

References (34)

1. Asakura H, Miura S, Morishita T et al. Endoscopic and histopathological study on primary and secondary intestinal lymphangiectasia. Dig. Dis. Sci. 1981 26 : 312 20.
2. Oh SJ, Jeltsch MM, Birkenhager R et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 1997 188 : 96 109.
3. Karkkainen MJ, Haiko P, Sainio K et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004 5 : 74 80.
4. Baldwin ME, Halford MM, Roufail S et al. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell Biol. 2005 25 : 2441 9.
5. Karkkainen MJ, Ferrell RE, Lawrence EC et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 2000 25 : 153 9.
6. Wigle JT, Harvey N, Detmar M et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002 2 : 1505 13.
7. Petrova TV, Karpanen T, Norrmen C et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 2004 10 : 974 81.
8. Ferrell RE. Research perspectives in inherited lymphatic disease. Ann. N. Y. Acad. Sci. 2002 979 : 39 51.
9. Irrthum A, Devriendt K, Chitayat D et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis- lymphedema-telangiectasia. Am. J. Hum. Genet. 2003 72 : 1470 8.
10. Karkkainen MJ, Saaristo A, Jussila L et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 2001 98 : 12677 82.
11. Lymboussaki A, Partanen TA, Olofsson B et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am. J. Pathol. 1998 153 : 395 403.
12. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 2000 6 : 2431 9.
13. de Waal RM, van Altena MC, Erhard H, Weidle UH, Nooijen PT, Ruiter DJ. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am. J. Pathol. 1997 150 : 1951 7.
14. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999 86 : 2406 12.
15. Kaipainen A, Korhonen J, Mustonen T et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 1995 92 : 3566 70.
16. Partanen TA, Arola J, Saaristo A et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000 14 : 2087 96.
17. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 2000 156 : 1499 504.
18. Banerji S, Ni J, Wang SX et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 1999 144 : 789 801.
19. Mouta Carreira C, Nasser SM, di Tomaso E et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 2001 61 : 8079 84.
20. Koukourakis MI, Giatromanolaki A, Sivridis E et al. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J. Clin. Pathol. 2005 58 : 202 6.
21. Jussila L, Valtola R, Partanen TA et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 1998 58 : 1599 604.
22. Lymboussaki A, Partanen TA, Olofsson B et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am. J. Pathol. 1998 153 : 395 403.
23. Valtola R, Salven P, Heikkila P et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am. J. Pathol. 1999 154 : 1381 90.
24. Yonemura Y, Endo Y, Fujita H et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 1999 5 : 1823 9.
25. Tsurusaki T, Kanda S, Sakai H et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br. J. Cancer 1999 80 : 309 13.
26. Achen MG, Williams RA, Minekus MP et al. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J. Pathol. 2001 193 : 147 54.
27. Zeng Y, Opeskin K, Baldwin ME et al. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin. Cancer Res. 2004 10 : 5137 44.
28. Krishnan J, Kirkin V, Steffen A et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF) -C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res. 2003 63 : 713 22.
29. Van Trappen PO, Steele D, Lowe DG et al. Expression of vascular endothelial growth factor (VEGF) -C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J. Pathol. 2003 201 : 544 54.
30. Zeng Y, Wang F, Williams ED, Chow CW. Lymphatics in the alimentary tract of children in health and disease: study on mucosal biopsies using the monoclonal antibody d2-40. Pediatr. Dev. Pathol. 2005 8 : 541 9.
31. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 2003 92 : 801 8.
32. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 1996 76 : 839 85. Review.
33. Saaristo A, Veikkola T, Tammela T et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 2002 196 : 719 30.
34. Saaristo A, Tammela T, Timonen J et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. 2004 18 : 1707 9.